BioXcel Therapeutics (BTAI) Stock Price
BioXcel Therapeutics Price
Over the last 5 years BioXcel Therapeutics grew revenue by 666.3% annually, reaching 642,000.00 USD. For BioXcel Therapeutics, the net margin of -10,887.4% is up versus -337,481,500.0% a few years ago.
BioXcel Therapeutics stock price
BioXcel Therapeutics business model & stock analysis
Frequently asked questions about BioXcel Therapeutics
7 analysts currently rate the BioXcel Therapeutics stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect BioXcel Therapeutics to generate revenue of 769,920.00 USD and earnings per share of -4.84 USD.
Converted at the current exchange rate, the BioXcel Therapeutics share trades at 0.04 EUR (0.05 USD).
The BioXcel Therapeutics share (BTAI) is listed on 4 stock exchanges, including: NASDAQ (BTAI), Frankfurt (BX2.F), München (BX2.MU), Düsseldorf (BX2.DU).
The expected revenue of BioXcel Therapeutics is 769,920.00 USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of BioXcel Therapeutics is -59.05 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of BioXcel Therapeutics is currently -0.01. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the BioXcel Therapeutics stock.
The price-to-sales ratio (P/S) of BioXcel Therapeutics is currently 0.76. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the BioXcel Therapeutics stock.
The Eulerpool Quality Score for BioXcel Therapeutics is 3/10.
The ISIN of BioXcel Therapeutics is US09075P2048. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of BioXcel Therapeutics is A2JF20. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of BioXcel Therapeutics is BTAI. The ticker symbol is used to trade BioXcel Therapeutics shares on the stock exchange.
BioXcel Therapeutics stock
BioXcel Therapeutics Peer Group
BioXcel Therapeutics Ticker
All fundamentals and in-depth analysis of BioXcel Therapeutics
Our stock analysis for BioXcel Therapeutics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioXcel Therapeutics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.